Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension

BackgroundThe prevalence of mental disorders, particularly adjustment disorder (AD), major depressive disorder (MDD) and panic disorder (PD) is increased in patients with pulmonary arterial hypertension (PAH). However, it is unclear which pathogenic mechanisms determine their development and could t...

Full description

Bibliographic Details
Main Authors: Flora Caldarone, Philippa Gebhardt, Marius M. Hoeper, Karen M. Olsson, Jan Fuge, Da-Hee Park, Tanja Meltendorf, Jan C. Kamp, Britta Stapel, Manuel J. Richter, Henning Gall, Hossein A. Ghofrani, Kai G. Kahl, Ivo Heitland
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.812812/full
_version_ 1828848318107615232
author Flora Caldarone
Philippa Gebhardt
Marius M. Hoeper
Marius M. Hoeper
Karen M. Olsson
Karen M. Olsson
Jan Fuge
Jan Fuge
Da-Hee Park
Da-Hee Park
Tanja Meltendorf
Tanja Meltendorf
Jan C. Kamp
Jan C. Kamp
Britta Stapel
Manuel J. Richter
Henning Gall
Hossein A. Ghofrani
Hossein A. Ghofrani
Kai G. Kahl
Ivo Heitland
author_facet Flora Caldarone
Philippa Gebhardt
Marius M. Hoeper
Marius M. Hoeper
Karen M. Olsson
Karen M. Olsson
Jan Fuge
Jan Fuge
Da-Hee Park
Da-Hee Park
Tanja Meltendorf
Tanja Meltendorf
Jan C. Kamp
Jan C. Kamp
Britta Stapel
Manuel J. Richter
Henning Gall
Hossein A. Ghofrani
Hossein A. Ghofrani
Kai G. Kahl
Ivo Heitland
author_sort Flora Caldarone
collection DOAJ
description BackgroundThe prevalence of mental disorders, particularly adjustment disorder (AD), major depressive disorder (MDD) and panic disorder (PD) is increased in patients with pulmonary arterial hypertension (PAH). However, it is unclear which pathogenic mechanisms determine their development and could therefore be targeted in prevention or therapeutic interventions. Here, we assessed metacognitions in a sample of PAH patients with and without MDD and PD. Moreover, we reconstructed the course of mental illnesses following the PAH diagnosis.MethodsTwo hundred seventeen PAH patients were included in this cross-sectional study. The prevalence of AD was assessed retrospectively using DSM-V criteria. Current mental disorders were assessed using the structured clinical interview for DSM-V. Additionally, metacognitive beliefs and processes were assessed using established questionnaires (MCQ-30, AnTI).ResultsPatients with an AD consecutive to the PAH diagnosis more frequently developed MDD (37.5 vs. 13.9%, p < 0.001) and PD (26.3 vs. 8.8%, p = 0.001) later on compared to PAH patients without a former AD. Moreover, patients with current MDD/PD displayed more dysfunctional metacognitions than those without current MDD/PD (p < 0.001). Patients with current MDD/PD in the context of former AD had more dysfunctional metacognitive worries and beliefs compared to patients with current MDD/PD without former AD (p = 0.009).ConclusionOur results suggest that in the context of PAH, dysfunctional metacognitions are associated with MDD and PD. Therefore, a metacognitive approach to treat and prevent those mental illnesses seems promising and should be investigated in future studies.
first_indexed 2024-12-12T22:26:40Z
format Article
id doaj.art-37a55f8661b04641bdd50c307bf20891
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-12T22:26:40Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-37a55f8661b04641bdd50c307bf208912022-12-22T00:09:43ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402022-04-011310.3389/fpsyt.2022.812812812812Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial HypertensionFlora Caldarone0Philippa Gebhardt1Marius M. Hoeper2Marius M. Hoeper3Karen M. Olsson4Karen M. Olsson5Jan Fuge6Jan Fuge7Da-Hee Park8Da-Hee Park9Tanja Meltendorf10Tanja Meltendorf11Jan C. Kamp12Jan C. Kamp13Britta Stapel14Manuel J. Richter15Henning Gall16Hossein A. Ghofrani17Hossein A. Ghofrani18Kai G. Kahl19Ivo Heitland20Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, GermanyDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL/BREATH), Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL/BREATH), Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL/BREATH), Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL/BREATH), Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, GermanyDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL/BREATH), Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL/BREATH), Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, GermanyDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, GermanyDepartment of Internal Medicine, German Center for Lung Research (DZL), Justus Liebig University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, GermanyDepartment of Internal Medicine, German Center for Lung Research (DZL), Justus Liebig University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, GermanyDepartment of Internal Medicine, German Center for Lung Research (DZL), Justus Liebig University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, GermanyDepartment of Pneumology, German Center for Lung Research (DZL), Kerckhoff Heart, Rheuma and Thoracic Center, Universities of Giessen and Marburg Lung Center, Bad Nauheim, GermanyDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, GermanyDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, GermanyBackgroundThe prevalence of mental disorders, particularly adjustment disorder (AD), major depressive disorder (MDD) and panic disorder (PD) is increased in patients with pulmonary arterial hypertension (PAH). However, it is unclear which pathogenic mechanisms determine their development and could therefore be targeted in prevention or therapeutic interventions. Here, we assessed metacognitions in a sample of PAH patients with and without MDD and PD. Moreover, we reconstructed the course of mental illnesses following the PAH diagnosis.MethodsTwo hundred seventeen PAH patients were included in this cross-sectional study. The prevalence of AD was assessed retrospectively using DSM-V criteria. Current mental disorders were assessed using the structured clinical interview for DSM-V. Additionally, metacognitive beliefs and processes were assessed using established questionnaires (MCQ-30, AnTI).ResultsPatients with an AD consecutive to the PAH diagnosis more frequently developed MDD (37.5 vs. 13.9%, p < 0.001) and PD (26.3 vs. 8.8%, p = 0.001) later on compared to PAH patients without a former AD. Moreover, patients with current MDD/PD displayed more dysfunctional metacognitions than those without current MDD/PD (p < 0.001). Patients with current MDD/PD in the context of former AD had more dysfunctional metacognitive worries and beliefs compared to patients with current MDD/PD without former AD (p = 0.009).ConclusionOur results suggest that in the context of PAH, dysfunctional metacognitions are associated with MDD and PD. Therefore, a metacognitive approach to treat and prevent those mental illnesses seems promising and should be investigated in future studies.https://www.frontiersin.org/articles/10.3389/fpsyt.2022.812812/fullpulmonary arterial hypertension (PAH)pulmonary hypertensionadjustment disorderdepressive disorderpanic disordermetacognitions
spellingShingle Flora Caldarone
Philippa Gebhardt
Marius M. Hoeper
Marius M. Hoeper
Karen M. Olsson
Karen M. Olsson
Jan Fuge
Jan Fuge
Da-Hee Park
Da-Hee Park
Tanja Meltendorf
Tanja Meltendorf
Jan C. Kamp
Jan C. Kamp
Britta Stapel
Manuel J. Richter
Henning Gall
Hossein A. Ghofrani
Hossein A. Ghofrani
Kai G. Kahl
Ivo Heitland
Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
Frontiers in Psychiatry
pulmonary arterial hypertension (PAH)
pulmonary hypertension
adjustment disorder
depressive disorder
panic disorder
metacognitions
title Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_full Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_fullStr Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_full_unstemmed Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_short Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_sort metacognitions in patients with frequent mental disorders after diagnosis of pulmonary arterial hypertension
topic pulmonary arterial hypertension (PAH)
pulmonary hypertension
adjustment disorder
depressive disorder
panic disorder
metacognitions
url https://www.frontiersin.org/articles/10.3389/fpsyt.2022.812812/full
work_keys_str_mv AT floracaldarone metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT philippagebhardt metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT mariusmhoeper metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT mariusmhoeper metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT karenmolsson metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT karenmolsson metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT janfuge metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT janfuge metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT daheepark metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT daheepark metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT tanjameltendorf metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT tanjameltendorf metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT janckamp metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT janckamp metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT brittastapel metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT manueljrichter metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT henninggall metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT hosseinaghofrani metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT hosseinaghofrani metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT kaigkahl metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT ivoheitland metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension